[1]
V. Pankiv, “Pharmacotherapeutic efficiency and advantages of the combined treatment of patients with type 2 diabetes mellitus”, Mìžnarodnij endokrinologìčnij žurnal, vol. 13, no. 6, pp. 435–439, Oct. 2017.